Seminar Title: Drug Development Today - Challenges and Possible Solutions

Seminar Location: Blue Bird Auditorium

Hosted by The Ting Tsung and Wei Fong Chao Center for BRAIN at Houston Methodist Hospital, this seminar series is dedicated to presenting the latest findings and technologies in neurobiology, drug development, biomarker discovery, and diagnostic and therapeutic advancements for neurodegenerative diseases and related disorders. The series aims to drive progress in understanding and treating these conditions by fostering collaboration and knowledge exchange among researchers and physicians in the field.

Speaker:

Johnson Y.N. Lau, MBBS, MD, FRCP

Executive Board Member

Avalon Biomedical 

Aiviva BioPharma 

Former Chair and CEO of U.S. publicly listed companies, including Ribapharm, the second-largest biotech IPO in U.S. history and Athenex Inc.